Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cabaletta Bio, Inc. - Common Stock
(NQ:
CABA
)
2.175
-0.045 (-2.03%)
Streaming Delayed Price
Updated: 1:47 PM EDT, Sep 24, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Cabaletta Bio, Inc. - Common Stock
< Previous
1
2
3
4
Next >
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 10/23
October 23, 2023
Via
Investor Brand Network
Cabaletta Bio Receives FDA Clearance of IND Application for Treatment of Systemic Sclerosis with CABA-201
October 02, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio to Participate in Upcoming Investor Conferences in September
September 19, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 9/12
September 12, 2023
Via
Investor Brand Network
Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in September
August 30, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 8/23
August 23, 2023
Via
Investor Brand Network
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 8/18
August 18, 2023
Via
Investor Brand Network
Cabaletta Bio and WuXi Advanced Therapies Announce Expansion of GMP Manufacturing Agreement to Include CABA-201
August 22, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
August 10, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Appoints Global Commercial Leader Shawn Tomasello to Board of Directors
July 24, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 7/18
July 18, 2023
Via
Investor Brand Network
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 7/12
July 12, 2023
Via
Investor Brand Network
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 5/18
May 18, 2023
Via
Investor Brand Network
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 5/2
May 02, 2023
Via
Investor Brand Network
Cabaletta Bio to Present at the Jefferies Healthcare Conference
May 31, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Announces Closing of $100 Million Public Offering of Common Stock, Including Full Exercise of Option to Purchase Additional Shares
May 22, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Announces Pricing of Public Offering of Common Stock
May 17, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Announces Proposed Public Offering of Common Stock
May 17, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Receives FDA Clearance of IND Application for CABA-201 for Treatment of Myositis
May 16, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Reports First Quarter 2023 Financial Results and Provides Business Update
May 11, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio to Present at the American Society of Gene and Cell Therapy 26th Annual Meeting
May 02, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Receives FDA Fast Track Designation for CABA-201
May 01, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ
April 25, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference
April 13, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Receives FDA Clearance of IND Application for CABA-201 for Treatment of Systemic Lupus Erythematosus
March 31, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
March 16, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio to Present at the Cowen 43rd Annual Health Care Conference
February 28, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Autolus Therapeutics Announces Collaboration with Cabaletta Bio for Use of Autolus’ Safety Switch System in Cell Therapies for Autoimmune Disease
January 09, 2023
From
Autolus Therapeutics plc
Via
GlobeNewswire
Cabaletta Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 05, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Announces $35 Million Offering
December 08, 2022
From
Cabaletta Bio
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.